Skip to main content

FDA Urged to Approve New Drug to Battle Heart Attacks

A federal panel of experts recommended that the Food and Drug Administration approve a new class of drugs to prevent heart attacks by lowering cholesterol.

Republish
Lead image for this article

A federal panel of experts recommended that the Food and Drug Administration approve a new class of drugs to prevent heart attacks by lowering cholesterol. The drugs are still in clinical trials, but the expert panel said some people who could benefit need the drugs now. (The New York Times)

Texans need truth. Help us report it.

Independent Texas reporting needs your support. The Texas Tribune delivers fact-based journalism for Texans, by Texans — and our community of members, the readers who donate, make our work possible. Help us bring you and millions of others in-depth news and information. Will you support our nonprofit newsroom with a donation of any amount?

Support independent Texas news

Become a member. Join today.

Choose an amount or learn more about membership.

$20 $25 $50 Other
Donate now

Information about the authors

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics